---
title: Sources
author: Corbin Cox
permalink: /sources
layout: diseases
last-updated: 2018-12-03
created: 2018-12-04
toc: true
common: false
---

# Cardiology

## ACS

### AHA NSTE-ACS Guidelines 2014

<p>
[^amsterdam2014]: Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology. 2014;64(24):e139-e228. doi:10.1016/j.jacc.2014.09.017
</p>

### AHA STEMI Guidelines
<p>
[^ogara2013]: O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. *Journal of the American College of Cardiology*. 2013;61(4):e78-e140. doi:[10.1016/j.jacc.2012.11.019](https://doi.org/10.1016/j.jacc.2012.11.019)
</p>
### Benign Early Repol vs Subtle LAD STEMI (4-variable)
<p>
[^driver2017]: Driver BE, Khalil A, Henry T, Kazmi F, Adil A, Smith SW. A new 4-variable formula to differentiate normal variant ST segment elevation in V2-V4 (early repolarization) from subtle left anterior descending coronary occlusion - Adding QRS amplitude of V2 improves the model. *Journal of Electrocardiology*. 2017;50(5):561-569. doi:[10.1016/j.jelectrocard.2017.04.005](https://doi.org/10.1016/j.jelectrocard.2017.04.005)
</p>

### DAPT Duration in CAD
<p>
[^levine2016]: Levine GN, Bates ER, Bittl JA, et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease. *Journal of the American College of Cardiology*. 2016;68(10):1082-1115. doi:[10.1016/j.jacc.2016.03.513](https://doi.org/10.1016/j.jacc.2016.03.513)
</p>

### LBBB vs STEMI
<p>
[^smith2012]: Smith SW, Dodd KW, Henry TD, Dvorak DM, Pearce LA. Diagnosis of ST-Elevation Myocardial Infarction in the Presence of Left Bundle Branch Block With the ST-Elevation to S-Wave Ratio in a Modified Sgarbossa Rule. *Annals of Emergency Medicine*. 2012;60(6):766-776. doi:[10.1016/j.annemergmed.2012.07.119](https://doi.org/10.1016/j.annemergmed.2012.07.119)
</p>

### Third Universal MI Definition
<p>
[^thygesen]: Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third Universal Definition of Myocardial Infarction. :16.
</p>

### STEMI PCI Update
<p>
[^levine2015]: Levine GN, Bates ER, Blankenship JC, et al. 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction. *Journal of the American College of Cardiology*. 2016;67(10):1235-1250. doi:[10.1016/j.jacc.2015.10.005](https://doi.org/10.1016/j.jacc.2015.10.005)
</p>

## HTN

### AHA HTN Guidelines
<p>
[whelton2018]: Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. *Journal of the American College of Cardiology*. 2018;71(19):e127-e248. doi:[10.1016/j.jacc.2017.11.006](https://doi.org/10.1016/j.jacc.2017.11.006)
</p>

# Critical Care

## Hypotension Management

### Push-Dose Pressors
<p>
[^weingart2015]: Weingart S. Push-dose pressors for immediate blood pressure control. *Clinical and Experimental Emergency Medicine*. 2015;2(2):131-132. doi:[10.15441/ceem.15.010](https://doi.org/10.15441/ceem.15.010)
</p>

<p>
[^hollenberg2011]: Hollenberg SM. Vasoactive Drugs in Circulatory Shock. American Journal of Respiratory and Critical Care Medicine. 2011;183(7):847-855. doi:[10.1164/rccm.201006-0972CI](https://doi.org/10.1164/rccm.201006-0972CI)
</p>

<p>
[^jentzer2015]: Jentzer JC, Coons JC, Link CB, Schmidhofer M. Pharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care Unit. Journal of Cardiovascular Pharmacology and Therapeutics. 2015;20(3):249-260. doi:[10.1177/1074248414559838](https://doi.org/10.1177/1074248414559838)
</p>

<p>
[^overgaard2008]: Overgaard CB, Džavík V. Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease. Circulation. 2008;118(10):1047-1056. doi:[10.1161/CIRCULATIONAHA.107.728840](https://doi.org/10.1161/CIRCULATIONAHA.107.728840)
</p>

# ID

## Vancomycin Dosing

### Optimizing Vancomycin Dosing
<p>
[^deryke2009]: Deryke CA, Alexander DP. Optimizing Vancomycin Dosing through Pharmacodynamic Assessment Targeting Area under the Concentration-Time Curve/Minimum Inhibitory Concentration. *Hospital Pharmacy*. 2009;44(9):751-765. doi:[10.1310/hpj4409-751](https://doi.org/10.1310/hpj4409-751)
</p>

### Vancomycin PK in Renal Dysfunction
<p>
[^matzkel1984]: Matzke GR, McGory RW, Halstenson CE, Keane WF. Pharmacokinetics of vancomycin in patients with various degrees of renal function. *Antimicrobial Agents and Chemotherapy*. 1984;25(4):433-437. doi:[10.1128/AAC.25.4.433](https://doi.org/10.1128/AAC.25.4.433)
</p>

### ASHP Vancomycin Monitoring Recommendations
<p>
[^rybak2009]: Rybak M, Lomaestro B, Rotschafer JC, et al. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. *American Journal of Health-System Pharmacy*. 2009;66(1):82-98. doi:[10.2146/ajhp080434](https://doi.org/10.2146/ajhp080434)
</p>

## Aminoglycoside Dosing

### Stanford Health System Aminoglycoside Dosing Recommendations
<p>
[^mui2017]: Mui, E. Stanford Health Care Aminoglycoside Dosing Guideline. 2017. [Link](http://med.stanford.edu/bugsanddrugs/dosing-protocols/_jcr_content/main/panel_builder/panel_0/download_2/file.res/Aminoglycoside%20Dosing%20Guide%202017-08-23.pdf)
</p>

### Extended Interval Aminoglycosides
<p>
[^nicolau1995]: Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. *Antimicrobial Agents and Chemotherapy*. 1995;39(3):650-655. doi:[10.1128/AAC.39.3.650](https://doi.org/10.1128/AAC.39.3.650)
</p>

# Textbooks

## Pharmacology

### DiPiro Pharmacotherapy
<p>
[^dipiro]: DiPiro JT, ed. *Pharmacotherapy: A Pathophysiologic Approach*. Tenth edition. New York: McGraw-Hill Education; 2017.
</p>

## Emergency Medicine

### Tintinalli's
<p>
[^tintinalli]: Tintinalli JE, Stapczynski JS, Ma OJ, Cline D, Meckler GD, Yealy DM, eds. *Tintinalli’s Emergency Medicine: A Comprehensive Study Guide*. Eight edition. New York: McGraw-Hill Education; 2016.
</p>

# Websites

## Drug Resources

### Lexicomp
<p>
[^lexi]: Lexi-Drugs. Lexicomp. Wolters Kluwer Health, Inc. Riverwoods, IL. Available at: http://online.lexi.com.
</p>